Life Technologies

Life Technologies Parkinson’s disease cell models—part 3

Issue link: http://life-technologies.uberflip.com/i/368629

Contents of this Issue

Navigation

Page 1 of 33

Contents Research summary 4 What is Parkinson's disease? 4 Collaboration summary 5 Methods 7 GeneArt ® Precision TALs technology overview 7 Workflow for genome editing of iPSCs 10 iPSC colony screening methods 12 GeneArt ® Genomic Cleavage Detection assay 12 TaqMan ® SNP Genotyping Assay 13 Ion PGM ™ sequencing 14 Exome sequencing for off-target modifications 16 Results 19 Generation of α-synuclein knockout lines in the MSA line 19 Screening for off-target modifications in the edited MSA lines 25 Correction of LRRK2 G2019S mutation in the PD-3 line 26 Correction of GBA N370S mutation in the PD-3 line 28 Summary, conclusions, and next steps 30 References 31 Ordering information 32 Find out more at lifetechnologies.com/parkinsons to be linked as buttons in UberFlip

Articles in this issue

Links on this page

view archives of Life Technologies - Life Technologies Parkinson’s disease cell models—part 3